TP53 and B-cell chronic lymphocytic leukemia: Almost two decades later, two TCL1-driven models of high-risk CLL have been generated with the conditional B-cell-specific deletion of Tp53 that displayed occasionally the features of RT with the occurrence of large CD5- blastoid cells in the splenic infiltrates (81).